Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 171 publications
Circumventing Ewing sarcoma tumor microenvironment resistance by IL1RAP CAR-modified TGFβ1-imprinted natural killer cells in combination with IL-15 agonist and anti-GD2 antibody.
Journal: Journal for immunotherapy of cancer
Published: June 24, 2026
Safety and clinical outcomes of a first-in-human trial of point-of-care manufactured trispecific CAR T cells targeting CD19, CD20, and CD22.
Journal: Blood cancer discovery
Published: May 18, 2026
CDK4/6 inhibition sensitizes breast cancer to NK cell therapy by inducing immune-interactive surface proteins.
Journal: bioRxiv : the preprint server for biology
Published: May 04, 2026
Safety and clinical outcomes of a first-in-human trial of point-of-care manufactured trispecific CAR T cells targeting CD19, CD20, and CD22.
Journal: Research square
Published: February 23, 2026
Erratum: Efficiently targeting neuroblastoma with the combination of anti-ROR1 CAR NK cells and N-803 in vitro and in vivo in NB xenografts.
Journal: Molecular therapy. Oncology
Published: February 09, 2026
A framework integrating multiscale in silico modeling and experimental data predicts CAR-NK cell cytotoxicity across target cell types.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: January 30, 2026
Molecular approaches drive the raceCAR team against cancer.
Journal: Molecular therapy. Oncology
Published: January 15, 2026
Trabectedin decreases myeloid resistance to improve the efficacy of anti-PD1 immunotherapy and delay glioma malignant progression.
Journal: Molecular therapy. Oncology
Published: October 15, 2025
IL-21-reprogrammed Vδ1 T cells exert killing against solid tumors which is enhanced by CAR arming for off-the-shelf immunotherapy.
Journal: Oncoimmunology
Published: September 25, 2025
CXCL10-induced chemotaxis of ex vivo-expanded natural killer cells combined with NKTR-255 enhances anti-tumor efficacy in osteosarcoma.
Journal: Molecular therapy. Oncology
Published: July 25, 2025
Natural killer cells in skin: a unique opportunity to better characterize the many facets of an overlooked secondary lymphoid organ.
Journal: Frontiers in immunology
Published: June 13, 2025
The impact of anticoagulant used for peripheral blood collection on NK cell yield, function, and proliferation.
Journal: Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis
Published: June 06, 2025
Last Updated: 09/26/2026